Putnam Investments’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
Putnam Investments's EXAS Position: Q4 2023 in Review
Putnam Investments increased its Exact Sciences (EXAS) stake by 0.08% in Q4 2023, buying an estimated $7.01K and bringing the position to 139,784 shares worth $10.3M. The position accounts for 0.01% of the portfolio, ranked #320.
Putnam Investments first reported a position in EXAS in Q2 2013 and has held it in 25 quarters since. The position peaked at $54.6M in Q1 2021. 647 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.
- Putnam Investments held 139,784 shares of Exact Sciences worth $10.3M as of Q4 2023.
- Putnam Investments bought 107 Exact Sciences shares in Q4 2023, an estimated $7.01K.
- Exact Sciences made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #320 holding.
- Putnam Investments first reported a position in Exact Sciences in Q2 2013 and has held it in 25 quarters since.
- Putnam Investments's Exact Sciences position peaked at $54.6M in Q1 2021.
- 647 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.